Annual Reports | Financial Reports | Invitations | List Of Owners | Financial Archive
FRE 25 AUG, 2023 09:00 CET
RLS Global delårsrapport april–juni 2023
ONS, 31 MAJ, 2023 08:30 CET
RLS Global delårsrapport januari–mars 2023
TIS, 28 FEB, 2023 08:30CET
RLS Global bokslutskommuniké oktober-december 2022
TOR, 24 NOV, 2022 08:00 CET
RLS Global delårsrapport juli–september 2022
FRE, 26 AUG, 2022 09:00 CET
RLS Global delårsrapport januari–juni 2022
ONS, 11 MAJ, 2022 09:00 CET
RLS Global delårsrapport januari–mars 2022
FRE, APR 22, 2022 08:00 CET
RLS Globals Årsredovisning 2021
FRE 25 FEB 2022 09:00 CET
RLS GLOBAL (publ) BOKSLUTSKOMMUNIKÉ 2021
FRE, 12 NOV, 2021 14:00 CET
RLS GLOBAL (publ) DELÅRSRAPPORT JULI-SEPTEMBER 2021
FRE, 16 JULI, 2021 09:00 CET
RLS GLOBAL (publ) DELÅRSRAPPORT JANUARI-JUNI 2021
FRE, MAJ 7, 2021 09:00 CET
RLS GLOBAL (PUBL) DELÅRSRAPPORT JANUARI-MARS 2021
FRE, APR 30, 2020 08:00 CET
RLS Globals Årsredovisning 2020
ONS, FEB 10, 2021 09:00 CET
RLS GLOBAL AB (PUBL) BOKSLUTSKOMMUNIKÉ 2020
TORS, NOV 12, 2020 09:00 CET
RLS GLOBAL AB (PUBL) DELÅRSRAPPORT JULI-SEPTEMBER 2020
FRE, JUL 17, 2020 08:30 CET
RLS GLOBAL AB (PUBL) DELÅRSRAPPORT JANUARI-JUNI 2020
FRE, MAJ 15, 2020 08:30 CET
RLS GLOBAL AB (PUBL) DELÅRSRAPPORT JANUARI-MARS 2020
MÅN, APR 27, 2020 08:30 CET
RLS Globals Årsredovisning 2019
FRI, FEB 14, 2020
RLS Global AB (publ) Bokslutskommuniké 2019
FRI, NOV 15, 2019
RLS Global AB (publ) Interim Report
JANUARY – SEPTEMBER, 2019
RLS Global is a Swedish MedTech company based in Gothenburg, founded in 1996. Through our advanced and unique Buffered Hypochlorite based Technology Platform we focus on developing products based on Gentle methods for Minimally Invasive Treatment.
RLS Global AB
Neongatan 5
SE 431 53 Mölndal
Sweden
Customer Services & Orders:
+46 31 780 68 20
customer@rlsglobal.com
Office
+46 31 780 68 20
customer@rlsglobal.com
I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
How does it work?
Using ChloraSolv
ChloraSolv consists of two solutions provided in a double syringe. The solutions are mixed to form a gel at the time of use. The gel is applied on the wound bed and allowed to act for 2 minutes to soften the devitalized tissue. A blunt instrument is then used to help in the mechanical removal devitalized tissue from the application site. Finish the procedure with a second application of the gel directly onto the wound area to completely clean the wound bed.
ChloraSolv – a valuable addition in the treatment of infected diabetic foot ulcers providing non-surgical debridement
We use cookies to help us deliver our services and provide personalised experiences. By using this website, you agree to our use of cookies.
